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OBJECTIVES: To compare the clinical and cost consequences of Gadoxetic Acid-
enhanced magnetic resonance imaging (PV-MRI) to extracellular contrast media-
enhanced MRI (ECCM-MRI) and Multidetector Computed Tomography (MD-CT) in
patients with suspected hepatocellular carcinoma (HCC) in South Korea and
Thailand. METHODS: The clinical pathway of patients with suspected HCC from
the initial imaging procedure (PV-MRI, ECCM-MRI or MD-CT) to the confirmed treat-
ment decision was presented in an economic decision-tree model. The model com-
pared payer relevant costs of the three diagnostic procedures as first line imaging
for suspected HCC and the subsequent costs to reach a confirmed treatment deci-
sion. The probabilities and resource consumptions were estimated and validated
by clinical experts through a Delphi panel process. Costs for diagnostic and treat-
ment options were derived from published sources. RESULTS:Using PV-MRI as first
imaging procedure in patients with suspected HCC evokes total cost of US$ 3,098/
patient in Korea. This is 0.1% higher than the costs for MD-CT (US$ 3,094/patient),
but 9.9% lower (US$ 306) than the costs of ECCM-MRI (US$ 3,405/patient). In Thai-
land, PV-MRI (US$ 702/patient) is the least costly alternative compared to ECCM-
MRI (US$ 930/patient) and MDCT (US$ 872/patient) and leads to cost savings of US$
228 US$and US$ 170, respectively. The higher acquisition cost of PV-MRI are more
than compensated by the cost saving achieved through the reduced need for con-
firmatory imaging procedures and the reduced need for changes in the surgical
protocol during resection. CONCLUSIONS: Using PV-MRI compared to ECCM-MRI
and MD-CT for the first imaging in patients with suspected HCC leads to relevant
cost savings for the statutory health insurance in both countries. The impact on
health outcomes (e.g. mortality, quality of life) and total cost needs to be shown in
an extended study approach.
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OBJECTIVES: The purpose of this study was to develop an economic impact model
to calculate and compare the net present cost of unicompartmental knee prosthe-
ses. These implants are used in knee arthroplasty procedures and are one of the
key cost drivers of the overall procedural cost. METHODS: A model was developed
using revision rates published in the Australian National Joint Replacement Regis-
try, to calculate the economic impact on health care systems. It was assumed that
the cost of the primary procedure remained constant regardless of the implant
used. Only prostheses reporting more than 1 year follow-up (n14) were included.
A sensitivity analysis was performed to examine the influence of varying time
horizons and discount rates. RESULTS: From a societal perspective, comparing the
predicted number of revisions and net present cost of revisions resulted in sub-
stantial differences between implants. The longer the time horizon, the greater the
differences reported between implants. The effect of different discount rates was
less than the effect of different time horizons. For a one time cohort of 2,500 pa-
tients, a time horizon of 5 years, a discount rate of 3.5% and a national reimburse-
ment rate for revision for an unicompartmental knee replacement of 10,000 Euros,
the net present cost for a national health care system could be as high as 4,500,000
Euros (all patients treated with the implant with the highest revision rate) or as low
as 1,200,000 Euros (all patients treated with the implant with the lowest revision
rate). CONCLUSIONS: This model may be utilized by health care systems or payers
to evaluate the economic impact of choosing implants with low revision rates.
Furthermore, the model allows for evidence-based pricing discussions. This study
provides important information, regardless of geography, for health systems and
payers to consider when selecting an implant for unicompartmental knee arthro-
plasty procedures.
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OBJECTIVES: Typical cost-effectiveness studies of CSII therapy focus on long-term
health-economic outcomes, with little emphasis on immediate clinical and eco-
nomic benefits which underpin long-term complication-related savings. The ob-
jective was therefore to evaluate the short-term health-economic outcomes of CSII
versus multiple daily injections (MDI), using best practice modelling methodology
with a focus on changes in glycosylated haemoglobin (HbA1c), severe hypoglycemic
events (SHE), insulin consumption and complication and insulin related (CIR) costs.
METHODS: The SWITCH costing model was developed based on regression equa-
tions for changes in HbA1c and SHE. Model inputs were derived from best available
evidence. Analysis was performed from a health care payer’s perspective for the
Netherlands. Model outputs included clinical benefits and potential reductions in
CIR costs. Sensitivity analysis determined the robustness of the results. RESULTS:
In a cohort representative of Netherlands, switching patients with poorly con-
trolled HbA1c on MDI [average HbA1c 9%; 0.2 SHE per patient year (PPY)] to CSII
results in the following calculated improvements PPY: 50% SHE potentially avoided
[€65 expenditure reduction (ER)], insulin dose reduction of 7,597 IU [€141 ER]; and a
relative HbA1c reduction of 12% [€406 ER]. The total calculated short-term improve-
ment in this subgroup is associated with potential savings in CIR cost of €612 PPY.
Similarly, switching patients with frequent SHE on MDI [average HbA1c 7%; 1.0 SHE
PPY] to CSII results in the following calculated improvements PPY: 80% SHE poten-
tially avoided [€523 ER], insulin dose reduction of 3,799 IU PPY [€71 ER]; and a
relative HbA1c reduction of 1% [€10 ER]. The total calculated short-term improve-
ment in this subgroup is associated with potential savings in CIR cost of €603 PPY.
CONCLUSIONS: In addition to long-term benefits; depending on baseline values,
switching patients from MDI to CSII potentially results in improved clinical out-
comes with significant reductions in short-term CIR costs.
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OBJECTIVES: To analyze cost, surgical time, hospitalization time, bleeding and
pain scores postoperatively, regarding patients who underwent thyroidectomy us-
ing vessel sealer system or harmonic scalpel technique compared to convencional.
METHODS: A retrospective study. Thyroidectomies performed between 2007 and
2010 (n  460), segmented by conventional or minimally invasive technique, used
to vessel sealer system or harmonic scalpel. Were analyzed: sex, age, principal
diagnosis, type of procedure (total thyroidectomy with or without lymphadenec-
tomy, thyroidectomy with or without lymphadenectomy). The outcomes analyzed
were duration of surgery, hospital stay, need for blood transfusions and pain score.
The conclusions were based on a significance level of 5% and statistical analyzes
were performed using the software R. RESULTS: The outcome duration of surgery,
the use of vessel sealer system resulted in increased duration of surgery about 47
minutes when compared to using the conventional technique (p0.001) and the use
of harmonic scalpel led to a reduction of the length mean surgery in approximately 32
minutes compared to the conventional technique (p0.001). Patients who used vessel
sealer system or harmonic scalpel had cost more than in patients with the conven-
tional technique. In relation to the outcome scores of pain and blood transfusion there
was no difference between the techniques.CONCLUSIONS: The use of harmonic scal-
pelwasfavorableintermsofreducingthedurationofsurgery,butwasn’tobservedimpact
on length of hospital stay and cost of the procedure was significantly higher (28%). Using
the vessel sealing system are no results in favorable outcomes assessed and the cost
increase was significant compared to the conventional technique.
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OBJECTIVES: Aortic valve replacement (AVR) the most common heart valve oper-
ation, accounts for a majority of all valve surgery performed in the elderly. Mini-
invasive aortic valve replacement (MiAVR) has several advantages over full ster-
notomy, mainly less surgical trauma, decreased blood loss, lower mortality and
faster recovery. However, it’s also associated with some draw-backs, as an in-
creased technical complexity and higher aortic cross-clamp circulation times
(CCTs). Perceval S is a new aortic valve which is implanted without need for sutur-
ing and a collapsed profile, thus allowing a significant reduction of cross-clamping
times, an independent risk factor for worse outcomes, allowing to expand the pool
of operable patients with MiAVR. Aim of this simulation study was to predict costs
and outcomes of isolated AVR procedures associated with this new valve in 4
European countries (Italy, France, Germany, and UK), as compared to traditional
valve implants, from the cost perspective of the hospital. METHODS: A probabilis-
tic, patient-level simulation model was fully coded in WinBugs, permitting a seam-
less integration of parameter estimation and outcomes prediction, which was en-
tirely based on the associated CCTs and on the surgical technique (mini-invasive
vs. full sternotomy), through published correlations. Unit cost were retrieved from
official and literature sources for all countries. Besides the incorporated probabi-
listic sensitivity analysis, a series of deterministic sensitivity analyses was
performed. RESULTS: The model predicts less complications with the use of the
Perceval S valve, and savings (valve cost excluded) ranging from slightly less than
6,000 € (Italy) to 6,700 £ (UK), mainly related to a reduction in surgery costs and
ICU/hospital bed days. Extensive sensitivity analyses confirm the robustness of
such findings. CONCLUSIONS: Reduced costs for the surgical procedure, shorter
hospital stay and complications mangament wtih Perceval S offset its increased
cost in all analysed countries.
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OBJECTIVES: To compare Gadoxetic Acid-enhanced MRI (PV-MRI) with extracellu-
lar contrast media-enhanced MRI (ECCM-MRI) and 3-phase MD-CT (MD-CT) in the
planning of surgery for patients with colorectal cancer liver metastases (CRCLM).
METHODS: A decision-tree model was used. The probabilities were collected and
validated by radiologists and liver surgeons in Germany, Italy and Sweden using a
Delphi panel process. Cost was derived from published sources and the mean costs
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